Biocon Share Price Dips 2.47%; Launches Liraglutide in the UK for Diabetes & Obesity

Biocon Limited has launched its GLP-1 peptide, Liraglutide, in the United Kingdom for the treatment of diabetes and obesity. The drug-device combination will be marketed under the brand names Liraglutide Biocon for diabetes (gVictoza®) and Biolide for chronic weight management (gSaxenda®).

On February 28, 2025, Biocon share price opened at ₹311.75, the same as its previous close of ₹311.85. At 10:54 AM, the share price of Biocon was trading at ₹304.15, down by 2.47% on the NSE.

Regulatory Approval and Market Entry

The launch follows approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K., making Biocon the first generics company to secure approval for gLiraglutide in a major regulated market. This approval highlights Biocon’s capabilities in developing complex GLP-1 peptide formulations and strengthens its position in the pharmaceutical industry.

Siddharth Mittal, CEO and Managing Director of Biocon Limited, emphasised that this launch is a major milestone in the company’s efforts to make essential diabetes and obesity treatments more affordable and accessible. The availability of gLiraglutide in the U.K. is expected to benefit patients and healthcare providers by providing a cost-effective alternative.

Conclusion

GLP-1 therapies are projected to be a key growth driver for Biocon. The company plans to expand its reach into other European markets, the U.S., and select MoW (Markets of the World) geographies. Biocon also aims to enhance its pipeline of GLP-1 peptide products, reinforcing its leadership in this sector.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Orient Technologies Joins Forces with AWS to Boost AI Development in India

Orient Technologies Ltd has announced a strategic collaboration with Amazon Web Services (AWS) India to enhance AI capabilities through advanced GPU and AI services.

By integrating AWS’s powerful GPU chips and AI-driven solutions, Orient Technologies aims to accelerate AI innovation and empower Indian businesses with world-class technology.

This partnership aligns with India’s growing focus on artificial intelligence, ensuring that companies can leverage cutting-edge tools to drive digital transformation efficiently.

AWS GPU Advantages for Cost Efficiency and Sustainability

AWS’s specialised GPU chips offer significant advantages over traditional computing solutions, reducing AI training costs by over 50% and enhancing overall affordability. These cost savings are crucial for the IndiaAI initiative, enabling broader participation and faster AI deployment.

Additionally, AWS GPUs provide 25% greater energy efficiency than conventional options, reinforcing India’s commitment to sustainable technology. With AWS’s support, IndiaAI can scale AI solutions globally, driving innovation and ensuring India remains at the forefront of AI advancements.

Commenting on the collaboration, the Director of Orient Technologies Limited, Umesh Shah, said, “Orient Technologies is excited to be part of this transformative journey and looks forward to harnessing AWS’s powerful tools and services to shape the future of AI in India. We are also proud to collaborate with MeitY in supporting mission-critical infrastructure across various national initiatives. With AWS’s support, we are poised to play a pivotal role in advancing IndiaAI mission and driving large-scale AI deployment and global innovation.”

He further added, “Together, we are dedicated to position India as a global AI leader and drive innovation that will benefit businesses and communities alike. Our continued engagement with MeitY reinforces our expertise in managing large-scale digital infrastructure. We remain dedicated to enabling secure and resilient technology solutions for India’s digital future.”

Conclusion

Through this collaboration, Orient Technologies and AWS are set to position India as a global leader in AI development, paving the way for groundbreaking technological progress.

On February 28, 2025, Orient Technologies share price (NSE: ORIENTTECH) opened at ₹317.65, touching the day’s high at ₹326.10, as of 10:06 AM on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Polycab Hits 52-Week Low on Feb 28; Wires and Cables Stocks Sees Mixed Reaction

Polycab India Ltd has been in focus on Friday. On February 28, 2025, Polycab share price opened at ₹4,650.00, down from its previous close of ₹4,679.55. At 9:45 AM, the share price of Polycab was trading at ₹4,809.40, up by 2.77% on the NSE. Notably, the stock price touched its 52-week low today at ₹4,555.00.

UltraTech’s Entry Into the Cables & Wires Segment

This focus has come on February 27 itself, after UltraTech Cement, a part of the Aditya Birla Group, announced its entry into the Cables and Wires (C&W) sector. The company aims to position itself as a comprehensive ‘Building Solutions’ provider. This move signals heightened competition in the segment, particularly for existing market leaders like Polycab.

On Feb 27, Polycab share price opened at ₹5,400.00 and touched its day’s low at ₹4,656.00.

Growth Potential in the Indian Wires & Cables Market

The Indian wires and cables market was valued at USD 8.71 billion in 2023 and is expected to reach USD 17.08 billion by 2032. Additionally, the electrical equipment market in India is projected to grow from USD 52.98 billion in 2022 to USD 125 billion by 2027, reflecting a CAGR of 11.68%. While UltraTech’s entry may introduce competitive pressures, the sector’s long-term growth prospects remain strong, driven by infrastructure expansion, industrial demand, and electrification initiatives.

Wires and Cables Stocks That Saw The Impact

This news not only impacted Polycab India, but also other wires and cables stocks, Kei Industries and Havells India. While these stocks traded in the red mostly on Feb 27, their performance today has been mixed.

On February 28, 2025, Kei share price opened at ₹2,974.00, down from its previous close of ₹2,999.05. At 9:49 AM, the share price of Kei Industries was trading at ₹3,070.95, up by 2.40% on the NSE.

Meanwhile, Havells share price opened at ₹1,438.00, down from its previous close of ₹1,451.25. At 9:51 AM, the share price of Havells was trading at ₹1,442.60, down by 0.60% on the NSE. The stock price touched its 52-week low on Feb 27 at ₹1,402.20.

On the other hand, UltraTech Cement share price opened at ₹10,490.00, up from its previous close of ₹10,447.65. At 9:50 AM, the share price of UltraTech Cement was trading at ₹10,396.75, down by 0.49% on the NSE.

Conclusion

The Indian wires and cables sector is poised for strong growth, but UltraTech’s entry introduces new competition that could impact market dynamics. Investors should closely monitor industry trends and company strategies before making investment decisions.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

VBL Share Price Rebounds on Feb 28 After Hitting 52-Week Low

Varun Beverages Ltd (VBL) has been in focus on Friday. On February 28, 2025, Varun Beverages share price (NSE: VBL) opened at ₹448.00, almost the same as its previous close of ₹448.30. At 9:39 AM, the share price of Varun Beverages was trading at ₹454.25, up by 1.33% on the NSE. Notably, the stock price touched its 52-week low at ₹439.90 on February 27, 2025.

Extension of Timeline for SBC Beverages Ghana Acquisition

Recently, on February 25, 2025, the company informed the stock exchanges about an extension in the timeline for acquiring 100% share capital of SBC Beverages Ghana Limited.

The acquisition, valued at US$ 15.06 million (₹1,271 million), is being executed through a Share Purchase Agreement with Ghana Bottling Company Limited. Initially scheduled for completion by February 28, 2025, as per the company’s earlier update on November 12, 2024, the transaction timeline has now been extended to March 31, 2025.

The completion remains subject to regulatory and other necessary approvals, including but not limited to approvals from PepsiCo Inc. The extension ensures smooth regulatory compliance and finalisation of procedural requirements for the acquisition.

Q3 FY 2025 Financial Highlights

For the quarter ended December 31, 2024, the company’s total income stood at ₹38,622.54 million, compared to ₹49,563.11 million in the previous quarter and ₹27,400.98 million in the same quarter last year.

Net profit after tax for the quarter was ₹1,956.44 million, down from ₹6,288.25 million in the previous quarter but higher than ₹1,437.62 million in Q3 FY24. For the year ended December 31, 2024, net profit reached ₹26,342.85 million, up from ₹21,018.13 million in the previous year.

About Varun Beverages Ltd

Varun Beverages Ltd, a key player in the beverage industry, has been associated with PepsiCo since the 1990s and is one of its largest global franchisees. The company manufactures and distributes a diverse range of carbonated soft drinks, non-carbonated beverages, and packaged water under PepsiCo-owned trademarks. Its portfolio includes popular brands such as Pepsi, 7UP, Mirinda Orange, Mountain Dew, Tropicana Juices, and more.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Schaeffler India Share Price in Focus; Reports 12.2% YoY Growth in Q4 2024 Revenue

Schaeffler India Limited has announced its financial results for the fourth quarter and full year ended December 31, 2024.

On February 28, 2025, Schaeffler share price opened at ₹3,086.30, up from its previous close of ₹3,076.95. At 9:30 AM, the share price of Schaeffler India was trading at ₹3,116.80, up by 1.30% on the NSE.

October – December 2024 (Fourth Quarter) Financial Highlights

For Q4 2024, the company reported a 12.2% year-on-year increase in revenue from operations, reaching ₹20,823 million, which was also 0.5% higher than Q3 2024. Profit before tax (PBT) stood at ₹3,387 million, reflecting a 12.7% increase from the same period last year. The PBT margin improved slightly to 16.3%, while the net profit for the quarter was ₹2,493 million, with a net profit margin of 12.0%.

January – December 2024 (Twelve Months) Financial Highlights

For the full year 2024, Schaeffler India recorded revenue from operations of ₹80,763 million, marking an 11.8% growth compared to 2023. The net profit for the year stood at ₹9,777 million, with a net profit margin of 12.1%, slightly lower than 12.6% in 2023.

Management Commentary 

Commenting on the results, the Managing Director and Chief Executive Officer, Mr Harsha Kadam, said, “I am pleased to share that we sustained double-digit YoY growth momentum consecutively for the third quarter, resulting also in a double digit growth of our annual performance. This was aided by our focus on new business wins and excellence in quality and delivery. We remained resilient despite a challenging market environment. Our focus on prudent financial management over the year will continue as we navigate the external headwinds entering 2025. Our consistent approach for dividend payments reiterates our commitment to providing sustainable, long-term value to our shareholders.”

Conclusion

These results reflect Schaeffler India’s operational efficiency and market demand. Despite slight margin contractions on an annual basis, the company showcased a consistent revenue growth.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Top Gainers and Losers on February 27, 2025: Shriram Finance & Bajaj Finance Shine

On February 27, 2025, the BSE Sensex was up by 0.01% closing at 74,612.43, while the Nifty50 was down by 0.01% at 22,545.05. Among sectors, Nifty Media and Nifty Realty declined by over 2% each.

Top Gainers of the Day

Symbol LTP (₹) Change(%)
SHRIRAMFIN 604 5.18
BAJAJFINSV 1,920.1 2.40
BAJFINANCE 8,660.75 2.03
HINDALCO 630.5 1.78
SUNPHARMA 1,642 1.76

  • Shriram Finance

Shriram Finance share price gained 5.18% after opening at ₹581.30. The stock touched the day’s high at ₹608.80.

  • Bajaj Finserv

Bajaj Finserv share price rose by 2.40%. The share price opened at ₹1,882.15 and touched its day’s high at ₹1,938.80.

  • Bajaj Finance

Bajaj Finance share price surged 2.03% after opening at ₹8,542.60. It hit a day’s high of ₹8,739.00.

  • Hindalco Industries

Hindalco share price surged 1.78% after opening at ₹625.10. It hit a day’s high of ₹633.90.

  • Sun Pharmaceutical Industries

Sun Pharma share price surged 1.76% after opening at ₹1,628.95. It hit a day’s high of ₹1,653.10.

Top Losers of the Day

Symbol LTP (₹) Change(%)
ULTRACEMCO 10,450 -4.69
TRENT 4,780 -3.63
BAJAJ-AUTO 8,195 -2.65
TATAMOTORS 647.75 -2.09
M&M 2,720 -2.08

  • UltraTech Cement

UltraTech Cement share price dropped 4.69%. The stock opened at ₹10,800.00 and touched its day’s low at ₹10,264.40. UltraTech has received an order from the Joint Commissioner, Dehradun – Sector 5, Uttarakhand, confirming a GST demand of ₹1.94 crore, plus interest and penalty. The company is reviewing the order and will determine its next steps.

  • Trent

Trent share price fell 3.63%. The share price opened at ₹4,951.00 and touched its day’s low at ₹4,770.10.

  • Bajaj Auto

Bajaj Auto share price fell 2.65%. The share price opened at ₹8,360.10 and touched its day’s low at ₹8,183.40.

  • Tata Motors

Tata Motors share price slipped 2.09%. The share price opened at ₹662.00 and touched its day’s low at ₹645.65.

  • Mahindra & Mahindra (M&M)

M&M share price slipped 2.08%. The share price opened at ₹2,837.00 and touched its day’s low at ₹2,703.50.

Conclusion

Today’s top gainers and losers reflect the stock market’s dynamic nature, influenced by corporate earnings, economic data, and global trends. Investors should stay updated and analyse market movements before making investment decisions.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Nifty Total Market Index Fund vs Direct Equity: Which Suits You?

The Nifty Total Market Index is designed to track the performance of 750 stocks across large, mid, small, and microcap segments via a single index. It includes all stocks from the Nifty 500 Index and the Nifty Microcap 250 Index, with stock weights determined by free-float market capitalisation. This broad-based index offers investors exposure to multiple sectors, making it a choice for those looking for diversified market participation.

Investors often debate between building a stock portfolio through direct equity investing or opting for a market-wide index fund like the Nifty Total Market Index Fund. Understanding the complexities of both approaches can help investors make informed decisions.

Stock Picking 

Direct equity investing involves selecting individual stocks to build a portfolio, which requires extensive research and active management. While it offers the potential for high returns, it can come with disadvantages such as:

  • Stock Selection Challenges: Identifying high-performing stocks demands in-depth knowledge of financial statements, market trends, and company fundamentals.
  • Sector-Specific Risks: Investing in limited sectors can expose investors to market volatility and economic downturns.
  • Time and Effort: Monitoring stock movements, quarterly earnings, and economic indicators is time-consuming.

The Simplicity of Investing in the Nifty Total Market Index Fund

Investing in the Nifty Total Market Index Fund eliminates the complexity of stock selection by offering exposure to all key sectors of the Indian economy.

The Nifty Total Market Index provides diversified exposure across multiple sectors, ensuring balanced market participation. If you look at the sector distribution, Financial Services holds the largest weight at 28.55%, followed by Information Technology (10.12%), Oil, Gas & Consumable Fuels (7.39%), and Fast Moving Consumer Goods (6.94%). Other key sectors include Automobile & Auto Components (6.87%), Healthcare (6.50%), and Capital Goods (5.94%). Apart from these, there are several other sectors included as well.

By investing in the Nifty Total Market Index Fund, investors can gain access to all these sectors without the need to pick individual stocks. The key benefits include:

  • Diversification: Exposure to various sectors can reduce the impact of poor performance in any single industry.
  • Long-Term Stability: Index funds follow overall market trends, offering steady growth potential.

Which Approach is Right for You?

For investors willing to take higher risks and actively manage their portfolios, direct equity investing may be suitable. However, for those seeking a low-cost, diversified, and hassle-free investment approach, the Nifty Total Market Index Fund can offer an efficient way to participate in the market’s long-term growth.

Angel One Nifty Total Market Index Fund

Angel One MF has launched two new Nifty Total Market Index Funds that consider Nifty Total Market TRI as the benchmark.

  • Angel One Nifty Total Market ETF
  • Angel One Nifty Total Market Index Fund

The new fund offer (NFO) was open from February 10 to February 21, 2025.

Angel One Nifty Total Market Index Fund invests 95% to 100% in equities and equity-related securities, including stocks and index derivatives. The remaining 0% to 5% of the assets are allocated to cash, cash equivalents, money market instruments, reverse repo, tri-party repo on government securities, treasury bills, or units of money market/liquid schemes.

Conclusion 

Overall, investors should assess their risk appetite and investment goals before choosing between passive index investing and active stock selection.

Ready to watch your savings grow? Try our SIP Calculator today and unlock the potential of disciplined investing. Perfect for planning your financial future. Start now!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Mutual Fund investments are subject to market risks, read all scheme-related documents carefully.

IREDA Share Price Sees Mixed Reaction on Feb 27 After QIP Announcement

Indian Renewable Energy Development Agency Limited (IREDA) has been in focus on Thursday. On February 27, 2025, IREDA share price opened at ₹173.55, the same as its previous close of ₹173.55. At 10:32 AM, the share price of IREDA was trading at ₹169.39, down by 2.40% on the NSE.

₹5,000 Crore QIP Approval & Government Stake Dilution

On February 24, 2025, IREDA shareholders approved a proposal to raise up to ₹5,000 crore through Qualified Institutions Placement (QIP) of equity shares in one or multiple tranches. The resolution was passed via remote e-voting during the 22nd Extraordinary General Meeting (EGM), chaired by CMD Shri Pradip Kumar Das. The plan also includes diluting the Government of India’s stake by up to 7% post-issue.

Shri Das highlighted IREDA’s strong financial performance, reporting a loan book of ₹68,960 crore, loan sanctions of ₹31,087 crore, and disbursements of ₹17,236 crore in the first nine months of FY 2024-25.

They further added that the QIP funds will enhance IREDA’s green financing capabilities and accelerate loan growth. Additionally, IREDA Global Green Energy Finance IFSC Limited, a wholly owned subsidiary, received regulatory approval to operate as a finance company at GIFT City, Gujarat, facilitating foreign currency lending and reducing hedging risks.

Conclusion

Through strategic fundraising and global expansion, IREDA aims to play a key role in advancing India’s clean energy ambitions while strengthening its financial position.

Post the announcement, on February 25, 2025, IREDA share price opened at ₹173.75 and touched the day’s high at ₹178.45 on the NSE.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

KPI Green Energy Share Price in Focus; Secures 1.8 GW Renewable Energy Project in Madhya Pradesh

KPI Green Energy Limited has been in focus on Thursday. On February 27, 2025, KPI Green Energy share price (NSE: KPIGREEN) opened at ₹410.00, up from its previous close of ₹397.65. At 10:09 AM, the share price of KPI Green Energy was trading at ₹400.55, up by 0.73% on the NSE.

Renewable Energy Agreement

KPI Green Energy announced on February 25, 2025, that KP Group signed a Memorandum of Understanding (MoU) with the New and Renewable Energy Department of Madhya Pradesh.

The MoU, signed during the Global Summit 2025 in Bhopal, aims to establish 1.8 GW of renewable energy projects, including solar, wind, hybrid, BESS, and biomass-based initiatives. This strategic collaboration highlights KPI Green Energy’s commitment to advancing India’s renewable energy landscape and aligns with the state and national clean energy targets.

Q3 FY 2024-25 Financial Performance

In Q3 FY 2024-2025, the company reported a total revenue of ₹466.1 crore, reflecting a substantial 40.6% increase from ₹331.33 crore in Q3 FY 2023-2024. This growth was driven by expanded project execution, increased capacity utilisation, and favourable market conditions.

Additionally, EBITDA stood at ₹144.54 crore, marking a strong 38% rise compared to ₹104.77 crore in the same period last year, showcasing the company’s operational efficiency and profitability.

The company also recorded a Profit After Tax (PAT) of ₹85.15 crore, reflecting an impressive 68.26% growth from ₹50.6 crore in Q3 FY 2023-2024.

Conclusion

KPI Green Energy’s partnership with the Madhya Pradesh government reinforces its commitment to renewable energy expansion. This move is expected to strengthen its growth prospects.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Caplin Point’s Subsidiary Secures USFDA Approval for Glaucoma Eye Drops

Caplin Point Laboratories Limited announced that its subsidiary, Caplin Steriles Limited, has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution (Eye Drops).

About the Approved Drug

The approved product, available in 5mL, 10mL, and 15mL fill presentations, is a generic therapeutic equivalent of COMBIGAN by AbbVie Inc. It is indicated for reducing elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.

According to IQVIA (IMS Health), Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution had U.S. sales of approximately $242 million for the 12-month period ending December 2024.

About Caplin Point Laboratories Limited

Caplin Point Laboratories Limited is a rapidly expanding pharmaceutical company with a distinctive business model focused on emerging markets in Latin America and Africa. The company operates state-of-the-art manufacturing facilities that produce a comprehensive range of finished dosage forms. Caplin Point is among the few firms that have demonstrated consistent, high-quality growth in cash flows, profitability, and revenue over the past 15 years.

On February 27, 2025, Caplin Point share price opened at ₹1,982.25, up from its previous close of ₹1,967.35. At 9:56 AM, the share price of Caplin Point was trading at ₹1,931.25, down by 1.83% on the NSE.

Conclusion 

This approval strengthens Caplin Steriles’ presence in the U.S. ophthalmic market and enhances its portfolio of sterile injectable and ophthalmic products.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.